biopharma merger

SEATTLE: AI Technology Group Inc. (OTCID: AIPG) said Friday it has filed an amended Form 10 with the U.S. Securities and Exchange Commission and signed a definitive agreement to acquire AVM Biotechnology Inc., a clinical-stage biopharmaceutical company developing a novel…